INTRODUCTION
============

Systemic arterial hypertension is a highly prevalent disease,[@b1-08-cs-0091],[@b2-08-cs-0091] affecting approximately one billion individuals worldwide, and is a major risk factor associated with increased all-cause and cardiovascular mortality.[@b2-08-cs-0091] Cardiovascular risk is dependent on systemic arterial blood pressure (BP), with optimal values below 120/80 mmHg.[@b2-08-cs-0091],[@b3-08-cs-0091] Systemic arterial hypertension treatments include lifestyle modifications and pharmacological interventions.[@b2-08-cs-0091] However, major pharmacological trials have demonstrated that maintaining BP at normal levels is difficult,[@b4-08-cs-0091] with only 25 to 62% of patients being properly controlled.[@b4-08-cs-0091]--[@b6-08-cs-0091]

Among lifestyle modifications, physical activity is important because it has been associated with a lower incidence of hypertension in different populations.[@b7-08-cs-0091]--[@b9-08-cs-0091] Additionally, physical activity reduces the BP of hypertensive and normotensive subjects,[@b10-08-cs-0091] with greater and longer-lasting reductions observed in subjects with higher BP levels.[@b14-08-cs-0091] Several studies have shown that just a single set of dynamic exercise can decrease BP to below basal levels in hypertensive subjects and that this hypotensive effect remains for several hours after exercise.[@b11-08-cs-0091]--[@b14-08-cs-0091] This acute exercise-mediated BP reduction is clinically significant.[@b14-08-cs-0091] However, post-exercise BP reduction has only been reported in uncontrolled hypertensive patients not taking medication; therefore, it is necessary to investigate whether this effect also occurs in long-term-treated hypertensive patients taking anti-hypertensive medications.

Thus, the goal of the present study was to evaluate the effect of a single bout of aerobic exercise on BP in patients receiving long-term anti-hypertensive treatment.

METHODS
=======

Study Design
------------

All volunteers were selected from the hypertension group at the University Hospital of the University of Sao Paulo. They underwent clinical evaluation and maximal graded exercise testing. Two 24 hour (24 h) ambulatory BP (ABP) monitoring were performed after a session of aerobic exercise (post-exercise) and after a nonexercise control period (control). The local ethics committee approved all procedures. The volunteers read a detailed description of the protocol and provided written informed consent.

Population
----------

Middle-aged hypertensive volunteers receiving treatment for arterial hypertension for 9.4 ± 6.1 years, with office BP \< 140/90 mmHg, without changes in drug therapy during the preceding 3 months or limitations on physical activity were recruited. Medical history and clinical evaluation were used to exclude persons with cardiovascular, renal, or pulmonary problems, diabetes, and chronic physical or psychological disorders. The maximal graded exercise test (Bruce protocol)[@b15-08-cs-0091] was performed to exclude the presence of coronary artery disease and determine the physical exercise workload. Because beta-blockers can greatly limit exercise-induced heart rate increases,[@b16-08-cs-0091] the maximal exercise test was performed at the same time of day as the exercise session with patients taking their current medication. Subjects participating in regular physical activity (more than once a week) for the last 6 months were also excluded. In all, 104 patients were screened. A total of 50 hypertensive patients (32 women; 21 postmenopausal) were eligible during the screening process and participated in the study. The reasons for ineligibility included uncontrolled office BP (28 patients), changes in drug therapy (5), type 2 diabetes (11 patients), and pre-participation in physical activity programs (10 patients). The demographics and drug regimens of the studied patients are summarized in [Table 1](#t1-08-cs-0091){ref-type="table"}. The results of the maximal exercise tests are displayed in [Table 2](#t2-08-cs-0091){ref-type="table"}.

24-h ambulatory blood pressure monitoring
-----------------------------------------

The 24 h ABP monitoring was performed after an exercise session (post-exercise) and after a nonexercise control period (50 minutes of rest in the sitting position) in random order using a Spacelabs model 90207 ABP monitor (Spacelabs Medical Inc., Redmond, WA). Both control and post-exercise 24-h ABP monitoring began at the same time of day (between 6 and 7 p.m.) and were separated by 2 to 7 days. All recordings were started on a weekday other than Friday.

Subjects were instructed to perform their habitual daily activities, not to engage in formal physical activity, and to relax and straighten the arm during the recording interval for daytime ABP monitoring. Subjects were also asked to document their hours of sleep, time at work, time at leisure activities, and time of medication. The monitor was programmed to measure BP every 15 minutes during the daytime and every 20 minutes during nighttime periods. The daytime and nighttime periods were based on the time patients got into and out of bed.

Individual BP measurements were reviewed for missing and erroneous values. Readings were purged if data were missing, systolic BP was lower than diastolic BP, systolic BP was \>240 mmHg or \<50 mmHg, or diastolic BP was \>140 mmHg or \<40 mmHg. System-tagged data were purged if systolic BP deviated by more than ± 50 mmHg or diastolic BP deviated by more than ± 20 mmHg from surrounding values. An average of 89.2±3.1 measurements was taken during each ABP monitoring session; 87.8±9.5% of measurements were then analyzed.

For analysis, 24-h ABP monitoring data were classified by 24-h, daytime, and nighttime periods for systolic, diastolic, and mean BP.

Exercise
--------

The exercise session took place in the evening (5 to 6 p.m.) and consisted of 40 minutes of aerobic exercise on a cycle-ergometer and 5 minutes of warm-up and cool-down. Exercise intensity was determined according to the workload reached during the maximal graded exercise test and was set at 60% of the reserve heart rate. The reserve heart rate was calculated by taking the difference between the peak and resting heart rates, then multiplying this number by the intensity of exercise, and adding it to the resting heart rate, according to the Karvonen method.[@b17-08-cs-0091] Peak and resting heart rates were obtained through the graded exercise test. Heart rates were monitored during all exercise sessions using a heart rate monitor (Polar Beat, Polar Electro Inc., Finland).

Statistical methods
-------------------

ANOVA was used to compare subject demographics between men and pre- and post-menopause women. Paired *t*-test was used to compare ABP monitoring data. Wilcoxon signed rank test was used to compare the percentage of patients with normal ABP monitoring data between control and post-exercise ABP measurements (24 h BP \< 130/80 mmHg, daytime BP \< 135/85 mmHg, and nighttime BP \< 120/70 mmHg).[@b18-08-cs-0091] Data are presented as the mean ± standard deviation. The level of significance was set at p ≤ 0.05. SPSS 13.0 software was used to perform statistical analyses.

RESULTS
=======

Because there were more women than men and more post- than pre-menopause women, we first compared the results based on sex and menopause status. However, ANOVA did not detect any effects of sex and menopause status for any measure. Thus, the results were not grouped by sex or menopause status.

Despite the fact that all patients were receiving antihypertensive therapy and office BP was \< 140/90mm Hg, only 14 patients showed normal control ABP levels for all reading periods. The prevalence of masked hypertension (office BP \< 140/90 mmHg but daytime ABP ≥ 135/85 mmHg)[@b18-08-cs-0091] was 52% and similar to the 48% observed for high nighttime ABP levels ([Table 3](#t3-08-cs-0091){ref-type="table"}).

Exercise was beneficial to ABP, as seen in [Figure 1](#f1-08-cs-0091){ref-type="fig"}. Statically significant post-exercise decreases were observed in systolic, diastolic, and mean 24-h ABP; diastolic daytime ABP; and systolic, diastolic, and mean nighttime ABP. Post-exercise systolic and mean daytime ABP tended to decrease (p=0.06).

[Figure 2](#f2-08-cs-0091){ref-type="fig"} shows that decreases in post-exercise ABP increased the prevalence of normal 24 h and daytime systolic ABP, as well as diastolic nighttime ABP. The prevalence of normal post-exercise 24h and daytime diastolic ABP did not increase significantly, but post-exercise systolic nighttime ABP tended to increase (p=0.058). These post-exercise BP improvements resulted in a decrease in the prevalence of masked hypertension from 52% (control) to 28% (post-exercise).

Because the effect of exercise on postexercise ABP reduction is related to the basal BP level,[@b14-08-cs-0091] we also separately analyzed the effect of exercise on subjects with higher and lower control ABP levels by subdividing them into groups with control ABP above and below the median values (see [Table 4](#t4-08-cs-0091){ref-type="table"}). Aerobic exercise only reduced ABP (by 2.6--7.1 mmHg) in the subjects with higher control ABP levels ([Figure 3](#f3-08-cs-0091){ref-type="fig"}).

DISCUSSION
==========

Exercise has been shown to markedly improve the function of a number of cardiopulmonary parameters[@b19-08-cs-0091]--[@b21-08-cs-0091] and aerobic power.[@b22-08-cs-0091] The primary finding of this research is that a single session of aerobic exercise reduced systolic, diastolic, and mean ABP in sedentary middle-aged long-term-treated hypertensive patients for a substantial portion of the subsequent 24 h period. This decrease resulted in an increased percentage of patients with normal ABP levels. To the best of our knowledge, this is the first study to evaluate the effects of a single bout of aerobic exercise on ABP in long-term-treated hypertensive patients who did not have a washout period before the start of the study.

Post-exercise BP reduction occurs in normotensive and untreated hypertensive, young, middle-aged, and older men and women.[@b12-08-cs-0091]--[@b14-08-cs-0091],[@b23-08-cs-0091] However, when BP is measured by ABP monitoring, post-exercise ABP reduction is only significant in untreated hypertensive and prehypertensive subjects; normotensive subjects showed no difference.[@b12-08-cs-0091],[@b14-08-cs-0091],[@b24-08-cs-0091] The present observations that only subjects with higher control ABP levels showed substantial decreases of systolic, diastolic, and mean ABP are consistent with these previous findings; however, the basal BP levels of treated hypertensive patients in this study were lower than the BP levels of untreated hypertensive in previous studies.[@b11-08-cs-0091]--[@b13-08-cs-0091],[@b25-08-cs-0091]

The average ABP reduction observed after exercise was similar to the post-exercise ABP reduction described in several other studies[@b13-08-cs-0091],[@b25-08-cs-0091] but greater than that observed in other studies where no ABP reduction was found.[@b11-08-cs-0091],[@b26-08-cs-0091] These discrepancies may be caused by different intensities of the exercise performed. In studies where no post-exercise ABP reductions were found, exercise was of either low[@b18-08-cs-0091] or maximal intensity.[@b26-08-cs-0091] Low-intensity aerobic exercise yields smaller and shorter-lasting ABP reductions than moderate-intensity aerobic exercise.[@b24-08-cs-0091] It is thus possible that low-intensity aerobic exercise is not sufficient to sustain post-exercise ABP reduction long enough to be detected by ABP monitoring. On the other hand, maximal exercise results in markedly different hemodynamic, hormonal, and neural responses than submaximal exercise; therefore, it is possible that a lack of sustained ABP reduction after maximal exercise[@b26-08-cs-0091] may be the result of the exercise intensity.

Although the population we studied consisted of hypertensive patients who were responsive to pharmacological treatment (office BP \< 140/90 mmHg), there was a high prevalence of masked hypertension (52%). Because the prevalence of masked hypertension in treated hypertensive patients has been shown to range from 7 to 20%,[@b18-08-cs-0091],[@b27-08-cs-0091] the hypertension treatments in the present study could be interpreted as ineffective. However, when only hypertensive patients responsive to treatment are analyzed, the prevalence of masked hypertension has been shown to range from 27 to 55%,[@b28-08-cs-0091] similar to the 52% observed in the present study.

In the present study, the percentage of subjects with normal ABP levels increased for all measurement periods after exercise. With this increase, 72% and 68% of patients reached normal daytime and nighttime normal ABP levels, respectively; this improvement represents a masked hypertension prevalence of 28% after exercise. These results show that aerobic exercise could facilitate antihypertensive treatment and, thus, improve patient prognoses.

Another important point of our study is the interval period between experimental protocols (exercise vs. nonexercise). Because this interval varied from 2 to 7 days, one could argue that patients who exercised first and then underwent the nonexercise session after 48 hours may still showing post-exercise effects during nonexercise 24 h ABP monitoring. However, previous studies have shown that although post-exercise hypotension may persist for up to 22 hours after exercise bout, it is usually not observed beyond the first 12 h.[@b14-08-cs-0091] Nonexercise measurements of patients who exercised first and then underwent the nonexercise session after 48 hours were therefore probably unaffected by earlier exercise session.

The exact mechanism for the post-exercise hypertension observed in the present study remains unclear but is most likely multifactorial. Acute decreases in BP by physical exercise may be related to reduced peripheral resistance rather than cardiac output, with the exception of older hypertensive subjects. Two mechanisms have been proposed to explain this decrease in peripheral resistance: sympathetic inhibition and altered vascular responsiveness after exercise.[@b14-08-cs-0091] Reduced sympathetic outflow after exercise has been reported in humans,[@b29-08-cs-0091],[@b30-08-cs-0091] but the mechanisms are unclear. Resetting the operating point of the arterial baroreflex to lower BP,[@b30-08-cs-0091] augmented GABA~A~ signaling in the rostral ventrolateral medulla,[@b31-08-cs-0091] and substance P receptors[@b32-08-cs-0091] in the nucleus tractus solitarius as well as central vasopressin V~1~ receptors[@b33-08-cs-0091] have all been shown to contribute to reduced sympathetic outflow after exercise session and, thus, may have contributed to the acute post-exercise BP reduction observed in the present study. Blunted vascular responsiveness to α-adrenergic stimulation,[@b30-08-cs-0091],[@b34-08-cs-0091] as well as increased local release of nitric oxide, prostaglandins, adenosine, and ATP,[@b30-08-cs-0091],[@b35-08-cs-0091] are also factors associated with changes in vascular responsiveness after acute exercise and may have also contributed to the post-exercise BP reduction observed in this study.

The main limitation of our study is that, although their BP levels were controlled by drug therapy, the subjects were using different quantities and qualities of medication; it is unknown whether different drugs may have influenced the post-exercise ABP reduction. Another limitation is that the exercise test was performed on a motor treadmill, while the exercise session was performed on a cycle-ergometer, as it has been shown that the heart rate response to treadmill exercise testing in sedentary subjects is 10--15% greater than the heart rate response to cycle-ergometer exercise testing.[@b36-08-cs-0091] Thus, we calculated 60% of the reserve heart rate on the treadmill and subtracted 10% to adjust it to the cycle-ergometer.

In summary, a single aerobic exercise session reduced ambulatory blood pressure in long-term-treated hypertensive patients and increased the percentage of subjects with normal ambulatory blood pressure levels. These effects suggest that aerobic exercise may be an important tool for blood pressure management of long-term-treated hypertension patients.
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###### 

Subjects' characteristics

  Variable                   Men           Women                                                    Total          
  -------------------------- ------------- -------------------------------------------------------- -------------- -------------
  N                          18            11                                                       22             50
  Age (years)                45.8 ± 9.8    40.4 ± 3.7 [\*](#tfn2-08-cs-0091){ref-type="table-fn"}   52.3 ± 3.4     46.5 ± 8.2
  BMI (kg/m^2^)              27.8 ± 3.8    28.9 ± 6.5                                               26.7 ± 4.2     27.8 ± 4.7
  Waist circumference (cm)   91.5 ± 9.6    90.7 ± 11.5                                              88.4 ± 11.3    90.1 ± 11.3
  Office BP (mmHg)                                                                                                 
   Systolic                  133.4 ± 7.2   130.5 ± 8.2                                              126.4 ± 10.6   129.6 ± 9.2
   Diastolic                 86.3 ± 3.1    85.1 ± 5.3                                               82.1 ± 8.1     85.3 ± 4.2
  Medication                                                                                                       
   Diuretic                  72%           54%                                                      59%            62%
   ACEI                      38%           27%                                                      40%            35%
   β-blocker                 33%           45%                                                      36%            38%
   CaCI                                                                                                            6%
   Mono-therapy              56%           63%                                                      50%            56%
   Combination-therapy       44%           37%                                                      50%            44%

N: number of patients; F: female; M: male; BMI: body mass index; ACEI: angiotensin-converting enzyme inhibitor; CaCI: calcium channel blocker. Mono-therapy: patients receiving single-drug therapy; Combination-therapy: patients receiving multiple-drug therapy.

: significant different from post-menopause women (p\<0.001)

###### 

Maximal exercise testing

  Variable              Non-β-blocker   β-blocker
  --------------------- --------------- --------------
  Exercise time (min)   7.0 ± 1.9       7.7 ± 2. 0
  METs                  7.3 ± 1.1       7.8 ± 1.3
  BP (mmHg)                             
  Rest                                  
   Systolic             134.6 ± 12.8    140.3 ± 15.2
   Diastolic            91.5 ± 9.8      93.3 ± 9.6
  Peak                                  
   Systolic             205.0 ± 25.1    214.0 ± 26.7
   Diastolic            102.1 ± 17.2    106.7 ± 11.1
  Heart Rate (bpm)                      
   Rest                 72.2 ± 7.7      70.7 ± 9.5
   Peak                 159.7 ± 16.2    160.2 ± 9.0
   % predicted          91.3 ± 8.2      91.0 ± 6.1

Non-β-blocker: patients do not receiving β-blocker therapy; β-blocker: patients receiving β-blocker therapy. BP: blood pressure.

###### 

Prevalence of normal ambulatory blood pressure

  Reading period   N    Percentage
  ---------------- ---- ------------
  24-hour          16   32 %
  Daytime          24   48 %
  Nighttime        26   52 %
  All Periods      14   28 %

Normal ABP: \< 130/80 mmHg for 24-h; \< 135/85 mmHg for daytime; and \< 120/70 for nighttime.

###### 

Median blood pressure values.

              SBP     DBP
  ----------- ------- ------
  24-hour     127.5   81.5
  Daytime     132.0   84.5
  Nighttime   116.5   73.5

SBP: systolic blood pressure; DMP: diastolic blood pressure; MBP: mean blood pressure.
